Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Metropolis Healthcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,958.20 |
52 Week High | ₹2,067.95 |
52 Week Low | ₹1,296.00 |
Beta | 0.31 |
1 Month Change | 5.83% |
3 Month Change | 22.85% |
1 Year Change | 44.82% |
3 Year Change | -29.10% |
5 Year Change | 97.50% |
Change since IPO | 104.01% |
Recent News & Updates
Recent updates
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next
May 24Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Shareholder Returns
METROPOLIS | IN Healthcare | IN Market | |
---|---|---|---|
7D | -2.2% | 5.3% | 2.7% |
1Y | 44.8% | 42.7% | 44.9% |
Return vs Industry: METROPOLIS exceeded the Indian Healthcare industry which returned 40.6% over the past year.
Return vs Market: METROPOLIS matched the Indian Market which returned 44.7% over the past year.
Price Volatility
METROPOLIS volatility | |
---|---|
METROPOLIS Average Weekly Movement | 4.4% |
Healthcare Industry Average Movement | 6.0% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.4% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: METROPOLIS has not had significant price volatility in the past 3 months.
Volatility Over Time: METROPOLIS's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 4,300 | Surendran Chemmenkotil | www.metropolisindia.com |
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates.
Metropolis Healthcare Limited Fundamentals Summary
METROPOLIS fundamental statistics | |
---|---|
Market cap | ₹100.32b |
Earnings (TTM) | ₹1.28b |
Revenue (TTM) | ₹12.08b |
78.5x
P/E Ratio8.3x
P/S RatioIs METROPOLIS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
METROPOLIS income statement (TTM) | |
---|---|
Revenue | ₹12.08b |
Cost of Revenue | ₹2.43b |
Gross Profit | ₹9.65b |
Other Expenses | ₹8.37b |
Earnings | ₹1.28b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 24.95 |
Gross Margin | 79.92% |
Net Profit Margin | 10.58% |
Debt/Equity Ratio | 0% |
How did METROPOLIS perform over the long term?
See historical performance and comparison